You are here

  • Home
  • Archive
  • Volume 68, Issue 7
  • Follow-on RifAximin for the Prevention of recurrence following standard treatment of Infection with Clostridium Difficile (RAPID): a randomised placebo controlled trial

Citation Tools

Article menu

Download PDFPDF

XML
Colon
Original article
Follow-on RifAximin for the Prevention of recurrence following standard treatment of Infection with Clostridium Difficile (RAPID): a randomised placebo controlled trial

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Major G, Bradshaw L, Boota N on behalf of RAPID Collaboration Group, et al
Follow-on RifAximin for the Prevention of recurrence following standard treatment of Infection with Clostridium Difficile (RAPID): a randomised placebo controlled trial
Gut 2019;68:1224-1231.